The growth of malignant and nonmalignant human cells is modulated by a human placental extract

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 429-436

  Angelucci, Cristiana ^a   Lama, Gina ^a   Sica, Gigliola ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cell growth; Malignant and nonmalignant cells; Placental extracts

Indexed keywords

ANTIMITOTIC AGENT; MEDPROTINE; PLACENTA EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; CULTURE MEDIUM; FIBROBLAST; HUMAN; HUMAN CELL; LEUKEMIA CELL; MONOLAYER CULTURE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

CELL DIVISION; CELL LINE; CULTURE MEDIA; HUMANS; PLACENTA; TISSUE EXTRACTS;

EID: 0032925056     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bianchim P. Osima B. Cetino MS. Tellini N and Morani A: Sostanze biologicamente attive in estratti di placenta. II Farmaco Ed Prat 32: 139-151, 1977.
2. Rauch S: Les effects d'un extrait placentaire sur l'epiderme humain. Riv Istoch Nom Pat 5: 325-336, 1959.
3. Berger M and Bergemann E: Action cicatrisante de preparations placentaires. Ther Umschau 12: 1-21, 1959.
4. Lolli R. Fanali S. Sarzani R and Torre M: Moderni aggiornamenti istopatologici sulfazione degli stimolanti biogeni nelle ferite operatorie in odontostomatologia. Parodont Stomatol 23: 61-66, 1984.
5. Gold-Aubert P, Chaumontet M and Capt M: An experimental study on the anti-inflammatory and anti-arthritic properties of a standardized placental extract. Int J Tiss React 3: 155-165, 1981.
6. Sany J, Combe B, Clot J, Andary A and Cosso B: Treatment of rheumatoid polyarthritis with IgG eluted from the placenta. Results of an open study on 31 patients. Rev Rheum Mal Osteartic 53: 473-479, 1986.
7. Carotti D and Allegra E: An approach to chemical characterization of human placental extracts, proteins peptides, and amino acids analyses. Physiol Chem Physics 13: 129-136, 1981.
8. Kanai-Azuma M, Kanai Y, Kurohmaru M, Sakai S and Hayashi Y: Insulin-like growth factor (IGF)-I stimulates proliferation and migration of mouse ectoplancental cone cells, while IGF-II transforms them into trophoblastic giant cells in vitro. Biol Reprod 48: 252-261, 1993.
9. O'Keefe EJ and Chiu ML: Stimulation of thymidine incorporation in keratinocytes by insulin, epidermal growth factor, and placental extract: comparison with cell number to assess growth. J Invest Dermatol 90: 2-7, 1988.
10. Pokidova NV, Zhuravleva TP and Ermol'eva ZV: Chemical and physicochemical properties of a placental protein with antitumor activity. Cancer Chemother Abstr 10: 349, 1969.
11. Letnansky K: Tumor-specific inhibition of DNA synthesis and cell proliferation by a factor from bovine placenta-possible mechanism. FEBS 171: 9-12, 1984.
12. Letnansky K: Isolation and characterization of a bovine placenta protein which specifically inhibits the proliferation of tumor cells. Immunobiol 175: 68, 1987.
13. Csaikl U, Csaikl F and Letnansky K: Inhibition of tumor cell proliferation by a novel growth regulator from placenta: modulation of membrane phosphorylation and oncogene expression. Cancer Lett 44: 227-231, 1989
14. Klein JL, Hamel E, Tayot JL and Yamasaki H: Growth suppression of transformed cells by a human placental extract not related to transforming growth factor β. J Cancer Res Clin Oncol 117: 192-196, 1991.
15. Klein JL, Chiodino C and Yamasaki H: Growth of only highly tumorigenic cell lines is inhibited by EAP, a human placental fraction. Cancer Lett 70: 91-99, 1993.
16. Fiore L, Scapagnini U and Canonico PL: Influence of a protein fraction (30-300 kDa) on ventral spinal cord neurons in culture. Acta Therapeutica 18: 255-261, 1992.
17. Drago F, Mauceri F, Valerio C and Lauria N: Effects of a protein fraction (M.W. 30-300KD) on the recovery of sensorimotor function in the rat. Acta Med Drug Rev: 5-7, 1993.
18. Lingetti M, Porfido FA and Ciarimboli M: Efficacia terapeutica di Bio Lucchini (P.A. frazioni proteiche 30 KD-300 KD) nel trattamento delle neuropatie compressive. Acta Med Drug Rev: 28-30, 1993.
19. Nencini P and Paroli E: Immunoreactive endorphin, enkephalinase inhibitory factors and ACTH-like activity in human placental fractions for therapeutic use. Rass Med Sper 28: 397-403, 1981.
20. Bevilacqua M, Vago T, Norbiato G: The role of melanotropins in nerve regeneration and immune defenses. Int J Immunother 13: 25-31, 1997.
21. Duc HT, Nakagawa S, Rucay P, Righenzi S, Voisin GA: Differential modulation of the in vitro lymphocyte activation pathways by soluble and solubilized placental substances. Am J Reprod Immunol 24: 73-79, 1990.
22. Dondi D, Limonta P, Moretti RM, Montagnani Marelli M, Garattini E and Motta M: Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop. Cancer Res 54: 4091-4095, 1994.